Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is considered the fourth leading cause of death worldwide. It is associated with a large number of comorbidities.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major epidemic disease in the world affecting 5 to 8% of all adults over the age of 40 years. It represents the fifth and the sixth cause of death in high and low income countries respectively (Mehrotra et al., 2009) 
.The Global Burden of Disease
Study has projected that COPD, will become the third leading cause of death worldwide by 2020. This increased mortality is mainly driven by the expanding epidemic of smoking, reduced mortality from other common causes of death (e.g. ischemic heart disease and infectious diseases) as well as due to aging of the world population (GOLD, 2011) .
Chronic obstructive pulmonary disease is a progressively disabling disease characterized by airflow obstruction that interferes with normal breathing. The most common cause is smoking which accounts for approximately 80% of COPD cases. Other causes include exposure to occupational hazards, air pollution and secondhand smoke (Fishwick et al., 2015) .COPD is strongly associated with occupational exposures during construction work and confirmed the increased COPD risk associated with exposures to asbestos, welding, silica, and cement dust. Other agents significantly associated with the risk of COPD included engine exhausts, acids, caustics, metal cutting and grinding aerosols, isocyanides, organic solvents, wood dust, molds and spores (John et al., 2015) .Wood, animal dung, crop residues, and coal, typically burned in open fires or poorly functioning stoves, may lead to very high levels of indoor air pollution.
Evidence continues to grow that indoor pollution from biomass cooking and heating in poorly ventilated dwellings is an important risk factor for COPD (Boman et al., 2006) . Almost 3 billion people worldwide use biomass and coal as their main source of energy for cooking, heating, and other household needs, so the population at risk worldwide is very large (Oroczo-Levi et al., 2006; Torres-Duque et al., 2008) .The genetic risk factor that is best documented is a severe hereditary deficiency of alpha-1 antitrypsin, a major circulating inhibitor of serine proteases. This rare recessive trait is most commonly seen in individuals of Northern European origin (Blanco et al., 2006) . Genetic associationstudieshave implicated a variety of genes in COPD pathogenesis, including transforming growth factor beta 1 (TGF-β1), microsomal epoxide hydrolase 1 (mEPHX1) and tumor necrosis factor alpha (TNF-α) (Wu et al., 2004) , However, the results of these genetic association studies have been largely inconsistent, and functional genetic variants influencing the development of COPD (other than alpha-1 antitrypsin deficiency) have not been definitively identified (Rabe et al., 2007) .Some patients develop COPD without smoking, but the nature of the inflammatory response in these patients is unknown. In addition to inflammation, two other processes thought to be important in the pathogenesis of COPD are an imbalance of proteases and antiproteases in the lung and oxidative Passive smokers group: 40 individuals in this group were nonsmoker males their ages ranged from 50 -63 years, and were selected with no history or symptoms of COPD or any other chronic respiratory disease but they were exposed to fumes, gases, dust and smoking (40 passive smokers).
Control Group: 27 volunteers in this group were normal healthy nonsmoker males; their ages ranged from 51 -64 years, and were selected with no history or symptoms of COPD or any other chronic respiratory disease (27 controls).
Methods: all patients and control were subjected to the following: -Thorough history taking, clinical examination, chest X-ray (posteroanterior and lateral views).
-Pulmonary function tests are FEV1: forced expiratory volume in first second, FVC: forced vital capacity and FEV1/FVC ratio % pred: percent predicted (Ranu et al., 2011 ).
-Arterial blood gases analysis (ABG):pH level of blood, partial pressure of carbon dioxide (Pco2) and partial pressure of oxygen (Po2) in arterial blood by using blood gas analyzer.
-Biochemical blood analysis such as CBC, ESR, alpha one antitrypsin (A1AT), C-reactive protein (CRP), serum & sputum nitric oxide (NO),fibrinogen, other liver function tests (ALT, AST&ALB)and kidneyfunction tests (BUN & Creatinine) (Ward and Cooper, 1975 ).
-Statistical analysis: the results were expressed as arithmetic means ± standard deviation (SD) . Differences between means were tested by one way ANOVA for the three groups. In order to evaluate the correlation between parametric variables, the Pearson's correlation test was utilized.
Data analysis was performed using SPSS version 20 software. P> 0.01 and p> 0.05 were considered statistically significant.
RESULTS
Results: in this study 40 COPD patients, 40 passive smokers and 27 healthy controls. All individuals were males. The results revealed that FEV1 and FEV1/FVC were decreased significantly in COPD patients > passive smokers > control group.
Results were expressed as means ± Standard Deviation (SD)
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 The results showed that pH level of ABG was the same in all groups with non-significant differences between all the three groups, while arterial carbon dioxide level of blood (Pco2) increased and arterial oxygen level of blood (PO2) decreased significantly inCOPD patients > passive smokers > control group.
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 The results showed that levels of kidney function tests were increased significantly in COPD patients as compared to passive smokers and control groups.
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 The results showed that levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were increased significantly in COPD patients as compared to passive smokers and control. Also serum albumin (ALB) levels decreased significantly in COPD patients as compared to passive smokers and control. While fibrinogen increased significantly in passive smokers compared to control group and also in COPD patients as compared to passive smokers and control groups.
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 Results were expressed as means ± Standard Deviation (SD)
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 The results indicated that levels of serum alpha one antitrypsin (A1AT) and serum nitric oxide (serum NO) were decreased significantly in passive smokers compared to control group and also in COPD patients as compared to passive smokers and control groups. While Serum C-reactive protein level (CRP) and Sputum nitric oxide (Sputum NO) were increased significantly in passive smokers compared to control group and also in COPD patients as compared to passive smokers and control groups.
The level of significance was accepted at P < 0.05 a = Statistical difference compared to control group at P < 0.05 b = Statistical difference compared to passive smokers at P < 0.05 et al., 2016) .
In our population FEV1 and FEV1/FVC were decreased significantly in passive smokers compared to control group and also in COPD patients as compared to passive smokers and control groups. Mukadder et al. (2002) found decreased levels of FEV1/FVC ratio and FEV1 in COPD patients rather than passive smokers and controls due to air way obstruction. This may be due to overlay variation in the true prevalence of airway obstruction and differences in the level of FEV1/FVC were the most clinically relevant diagnostic criterion for COPD. Decrease in FEV1 increase mortality due to cardiovascular complication which increased in patients with COPD agreeing with Swanney et al. (2008) (Sunil and Mansi 2010) and Wouter et al. (2015) .
In our study a significant increase in the partial pressure of arterial carbon dioxide (Pco2) and a significant decrease in the partial pressure of arterial oxygen (Po2) in COPD patients compared to passive smokers and controls. This finding was in line with Ahmet et al.(2006) and (Jindal, 2008) who found that decreased (Po2) produced hypoxemia at decreased ventilation of lungs or in the case of extensive pathological processes in respiratory system leading to alveolo-capillary blockage. At reduced oxygen tension in pulmonary capillaries hemoglobin in red cells cannot fully saturated with oxygen and therefore hypoxemia develops. The results of the present study illustrated a significant increase in serum BUN and creatinine in COPD patients when compared to passive smokers and controls as reported by Tozawa et al. (2002) and Satarug et al. (2004) .
This may be explained by the presence of both nicotine and selected heavy metals as lead and cadmium, which are components of smoke, are risk factors for chronic renal failure. They cause nephrotoxicity in the form of tubular proteinuria and glomerular dysfunction evidenced by an increased excretion of high molecular weight proteins and increased levels of creatinine in plasma, and giving rise to a glomerular type proteinuria agreeing with Gjerde et al. (2012) and Chandra et al. (2012) .
In the present study a significant increase in levels of transaminases (ALT and AST) in COPD patients as compared to passive smokers and controls. This may be due to A1AT deficiency agreeing with Morisco et al. (2008) and (Silverman and Sandhaus, 2009 ).
In our work a significant decrease in serum albumin level in COPD patients when compared to passive smokers and controls. This finding was in accordance with Gunen et al. (2005) , who found that low albumin levels, considered to be part of the acute phase protein response. Low levels of this protein reflect a deterioration of clinical status or increased persistent inflammation during acute exacerbations of COPD.Hypoalbuminemia is a strong prognostic risk factor for acute respiratory failure and malnutrition in COPD as reported by Zaky et al. (2014) .
Our study agreed with that of Marie et al.(2012) , a significant increase in serum fibrinogen level in COPD patients compared to passive smokers and controls. This was also suggested by the studies of Pertseva et al. (2013) , Yoko et al. (2013) and Sofie et al. (2014) , who explained that plasma levels of fibrinogen were higher in COPD patients compared to controls and these levels were associated with a degree of airflow limitation, which is one of the parameters used to assess the severity of COPD. Higher fibrinogen levels were associated with the rate of decline in the pulmonary functions FEV1/FVC in COPD patients and suggest that plasma fibrinogen may be a potent biomarker for pulmonary dysfunction.
The results of the present study represented significant increase in erythrocyte sedimentation rate (ESR) in COPD patients when compared to passive smokers and controls. These findings were compatible with Gulfidan Krzysztof et al. (2011) and (Behzad, 2012) , who explained that causes of increased ESR are anemia, macrocytosis, increased number of high molecular weight proteins in the blood, elevating plasma viscosity and thus would raise the ESR. Also fibrinogen, the most abundant acute phase proteins reactant, has the greatest effect on the elevation of ESR.
The present study showed that a significant decrease in Hb of patients with COPD compared to passive smokers and controls. This finding was in line with Davood et al. (2009) . This may reflect the balance between the stimulation of erythropoiesis by hypoxia and its depression by inflammation agreeing with (Abebaw and William, 2011) . Therefore hypoxia occurs when the oxygen pressure in blood going to the tissues is too low to saturate the hemoglobin. It is characterized by a lack of oxygen entering the blood and the inability to diffuse the oxygen across the lungs as reported by Tsui et al. (2011) . The present study showed that a significant decrease in platelet count of COPD patients as compared to passive smokers. These findings are consistent with Wang et al. (2013) . This may be due to the consumption of platelets under high-grade inflammatory conditions. Increased levels of inflammatory proteins such as CRP, fibrinogen, and proinflammatory cytokines observed in COPD may be associated with decreased platelets.
The results of the present study showed that a significant increase in levels of white blood cell count ( The results of the present study illustrated a significant increase in serum CRP level in COPD patients when compared to passive smokers and controls.
This agreed with Agarwal et al. (2013) and Montano et al. (2014) , who proved that the elevated levels of CRP in COPD patients suggest that systemic inflammation stimulates CRP synthesis. Also as reported by Zhang et al. (2012) .Theelevated levels of CRP in COPD patients may result from chronic hypoxia, hypermetabolism, malnutrition, skeletal muscle fiber-type shifting and endocrine disorder.
Our results agreed with that of Panchal et al. (2014) , who found that a significant decrease in serum A1AT level in COPD patients when compared to passive smokers and controls. This may be due the result of direct oxidation of its reactive center by free radicals in the smoke and also by oxygen radicals released from the activated leucocyte. This increased production of elastase, together with a decrease in its inhibitory activity, results in an attack on the lower respiratory tract and the development of emphysema.
In the present study, there was a significant decrease in serum NO level and increase in sputum NO level of COPD patients when compared to passive smokers and controls. This may be explained by the unstable structure of NO and reactions between NO and toxic oxygen anion radicals (O2-) to form 
